Corpus Intelligence IC Memo — PLEASANT VALLEY HOSPITAL 2026-04-26 03:50 UTC
IC Memo — PLEASANT VALLEY HOSPITAL
Investment Committee Memorandum | WV | 49 beds | Grade C | EBITDA uplift $2.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PLEASANT VALLEY HOSPITAL

CCN 510012 | MASON, WV | 49 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PLEASANT VALLEY HOSPITAL is a 49-bed under-performing / distressed in MASON, WV with $39.9M in net patient revenue and a -48.1% operating margin. The hospital serves a payer mix of 43.4% Medicare, 3.1% Medicaid, and 53.5% commercial.

Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -48.1% to -40.7% (+736bps).

Net Revenue HCRIS$39.9M
Current EBITDA COMPUTED$-19.2M
Operating Margin COMPUTED-48.1%
Occupancy HCRIS33.5%
Revenue / Bed COMPUTED$814K
Net-to-Gross HCRIS26.9%
Distress Probability ML52.4%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
36
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -48.1% places it below the state median. Among 36 size-comparable peers (24-98 beds), the median margin is 2.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 36 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PLEASANT VALLEY HOSPITAL (Target)WV49$39.9M-48.1%
REYNOLDS MEMORIAL HOSPITALWV94$123.6M3.8%
BECKLEY ARHWV72$109.2M-37.8%
ST. JOSEPHS HOSPITAL OF BUCKHAWV25$101.4M15.7%
DAVIS MEMORIAL HOSPITALWV90$100.9M-20.4%
JEFFERSON MEMORIAL HOSPITALWV25$85.5M9.7%
POTOMAC VALLEY HOSPITALWV25$69.5M16.2%
BOONE MEMORIAL HOSPITALWV25$61.8M-12.0%
SUMMERSVILLE REGIONAL MED CENTWV25$60.6M0.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$837K+210bp18mo
Cost to Collect4.5%2.5%$797K+200bp12mo
Denial Rate Reduction12.0%6.5%$789K+198bp12mo
A/R Days Reduction5200.0%3800.0%$485K+122bp9mo
Clean Claim Rate88.0%96.0%$26K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$837K
Cost to Collect
$797K
Denial Rate Reduction
$789K
A/R Days Reduction
$485K
Clean Claim Rate
$26K
Total EBITDA Uplift$2.9M
Current EBITDA$-19.2M
+ RCM Uplift+$2.9M
Pro Forma EBITDA$-16.2M
Current Margin-48.1%
Pro Forma Margin-40.7%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-29.5M$-97.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-29.5M$-116.3M0.00x-100.0%
Bull Case9.0x11.0x$-26.5M$-116.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-26.5M$-134.6M0.00x-100.0%
Bear Case11.0x10.0x$-32.4M$-102.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-32.4M$-122.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 33.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 36 hospitals with 24-98 beds
  • Same-state prioritization (n=37)
  • Comp margins: P25=-12.3% / P50=2.6% / P75=10.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.